De novo biosynthesis of lavandulol and lavandulyl acetate in Escherichia coli | Synapse
March 3, 2026
De novo biosynthesis of lavandulol and lavandulyl acetate in Escherichia coli
Puntos clave
Successful de novo biosynthesis of lavandulol and lavandulyl acetate was accomplished using engineered escherichia coli strains, showcasing metabolic engineering advances.
The engineered strains exhibited significant production yields of lavandulol and lavandulyl acetate, with specific concentrations reported in the study.
Metabolic engineering was employed to modify the pathways in escherichia coli for the efficient synthesis of these valuable compounds.
These findings highlight the potential for using bacterial systems in producing natural fragrances and other bioactive compounds.